In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome: Figure 1
Laurence Faivre(Inserm), Valérie Cormier‐Daire(Institut Necker Enfants Malades), Arnold Münnich(Hôpital Necker-Enfants Malades), Cathérine Boileau(Inserm), Nathalie Dagoneau(Hôpital Necker-Enfants Malades), Mary K. Wirtz(Legacy Health), Martine Le Merrer(Hôpital Necker-Enfants Malades), Gwenaëlle Collod‐Béroud(Hôpital Necker-Enfants Malades), Maurice Godfrey(University of Nebraska Medical Center), J. R. Samples(Oregon Health & Science University), Robert J. Gorlin(University of Minnesota)
Cited by 281
Related Papers
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
|European Heart Journal|2014|1.1k
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
|European Heart Journal|2015|868
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
|Nature Genetics|2001|819